Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

In Vitro Analysis of the Herbal Compound Essiac®

DUGALD SEELY, DEBORAH A. KENNEDY, STEPHEN P. MYERS, PHILLIP A. CHERAS, DAVID LIN, RACHEL LI, TRUDY CATTLEY, PETTA-ANNE PAUL BRENT, EDWARD MILLS and BLAIR J.N. LEONARD
Anticancer Research November 2007, 27 (6B) 3875-3881;
DUGALD SEELY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dseely@ccnm.edu
DEBORAH A. KENNEDY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN P. MYERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILLIP A. CHERAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID LIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RACHEL LI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TRUDY CATTLEY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETTA-ANNE PAUL BRENT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EDWARD MILLS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BLAIR J.N. LEONARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Despite the recommendation of the Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative, little research has been published on the widely used herbal compound Essiac®. We aimed to address this deficiency by conducting a series of assays to determine some of the purported activities of Essiac® in vitro. Materials and Methods: The activity of Essiac® was measured using established assays to assess anti-oxidant, fibrinolytic, anti-microbial, anti-inflammatory, immune modulation, cell-specific cytotoxicity, and impact on cytochrome P450 (CYP450) enzyme pathways. Results: Essiac® exhibited significant antioxidant activity in the ABTS assay. A 20-fold dilution of Essiac® also exhibited significant immunomodulatory effects, specifically through stimulation of granulocyte phagocytosis, increases in CD8+ cell activation, and moderately inhibiting inflammatory pathways. Essiac® exhibited significant cell-specific cytotoxicity towards ovarian epithelial carcinoma cells (A2780). Importantly, a 20-fold dilution of Essiac® showed significant inhibition of several CYP450 enzymes, most notably CYP1A2 (37%) and CYP2C19 (24%). Essiac® demonstrated dose-dependent inhibition of clot fibrinolysis. Conclusion: In vitro analysis of Essiac® indicates significant antioxidant and immunomodulatory properties, as well as neoplastic cell specific cytotoxicity consistent with the historical properties ascribed to this compound. Importantly, significant CYP450 and fibrinolysis inhibition were also observed. This is the first comprehensive investigation of the in vitro effects of Essiac®.

  • Essiac®
  • in vitro
  • breast cancer
  • prostate cancer
  • herbal medicine
  • complementary and alternative medicine

Footnotes

  • Received February 21, 2007.
  • Revision received August 21, 2007.
  • Accepted October 4, 2007.
  • Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 27 (6B)
Anticancer Research
Vol. 27, Issue 6B
November-December 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro Analysis of the Herbal Compound Essiac®
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
13 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
In Vitro Analysis of the Herbal Compound Essiac®
DUGALD SEELY, DEBORAH A. KENNEDY, STEPHEN P. MYERS, PHILLIP A. CHERAS, DAVID LIN, RACHEL LI, TRUDY CATTLEY, PETTA-ANNE PAUL BRENT, EDWARD MILLS, BLAIR J.N. LEONARD
Anticancer Research Nov 2007, 27 (6B) 3875-3881;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
In Vitro Analysis of the Herbal Compound Essiac®
DUGALD SEELY, DEBORAH A. KENNEDY, STEPHEN P. MYERS, PHILLIP A. CHERAS, DAVID LIN, RACHEL LI, TRUDY CATTLEY, PETTA-ANNE PAUL BRENT, EDWARD MILLS, BLAIR J.N. LEONARD
Anticancer Research Nov 2007, 27 (6B) 3875-3881;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases
  • Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer
  • Changes in Lysophospholipid Components in Ulcerative Colitis and Colitis-associated Cancer
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2022 Anticancer Research

Powered by HighWire